Aldactazide

Aldactazide

 [al-dak´tah-zīd]
trademark for a preparation of spironolactone and hydrochlorothiazide, a diuretic.

Aldactazide

a trademark for a fixed-combination drug containing a thiazide diuretic (hydrochlorothiazide) and a potassium-sparing diuretic (spironolactone).

Aldactazide

A combination of spironolactone (an aldosterone antagonist) and hydrochlorothiazide (a diuretic and antihypertensive) used to manage essential hypertension and fluid retention/heart failure, cirrhosis and oedema/ascites, and nephrotic syndrome.
 
Adverse effects
Hypotension (including orthostatic), pancreatitis, jaundice, aplastic anaemia, agranulocytosis, leukopenia, haemolytic anaemia, thrombocytopenia, hypersensitivity, and electrolyte imbalance.
References in periodicals archive ?
Sparing + Thiazide) Amiloride/HCTZ Several generics 5/50(1-2) Spironolactone/HCTZ Aldactazide 25/25 (1/2-1) Triamterene/HCTZ Dyazide 37.
Some of these combinations are Dyazide, Moduretic, Maxzide or Aldactazide.